Document:

Exhibit 10.6

   

  SECURITIES
        PURCHASE AGREEMENT

   

  This
      Securities Purchase Agreement (this “Agreement”) is dated as of September 3, 2021, between Metro One Telecommunications,
      Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including
      its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

   

  WHEREAS,
      subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
      (the “Securities Act”), and Rule 506(b) promulgated thereunder, the Company desires to issue and sell to each Purchaser,
      and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described
      in this Agreement (the “Offering”).

   

  NOW,
      THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
      and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

   

  ARTICLE
        I.

  DEFINITIONS

   

  1.1 Definitions.
      In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
      set forth in this Section 1.1:

   

  “Acquiring
        Person” shall have the meaning ascribed to such term in Section 4.4.

   

  “Affiliate”
      means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
      with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

   

  “Board
        of Directors” means the board of directors of the Company.

   

  “Business
        Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
      on which banking institutions in the State of New York are authorized or required by law or other governmental action to close; provided, however,
      for clarification, banking institutions in the State of New York shall not be deemed to be authorized or required by law to remain closed
      due to “stay at home”, “shelter-in-place”, “non-essential employee”  or any other similar orders
      or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
      funds transfer systems (including for wire transfers) of banking institutions in the State of New York or are generally are open for
      use by customers on such day.

    

  “Closing”
      means the closing of the purchase and sale of the Units pursuant to Section 2.1.

   

  “Closing
        Date” has the meaning set forth in Section 2.1(b).

   

  “Commission”
      means the United States Securities and Exchange Commission.

   

  “Common
        Stock” means the common stock of the Company, $0.0001 par value per share, and any other class of securities into which such
      securities may hereafter be reclassified or changed. 

   

  “Common
        Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
      at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
      at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

   

  “Disclosure
        Schedules” means the Disclosure Schedules of the Company delivered concurrently herewith.

   

  

  
  
    1

  

  
     

  

  
   

  “Exchange
        Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

   

  “FCPA”
      means the Foreign Corrupt Practices Act of 1977, as amended.

   

  “Liens”
      means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

   

  “Material
        Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

   

  “Per
        Unit Purchase Price” equals $0.075, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
      and other similar transactions of the Common Stock that occur after the date of this Agreement

   

  “Person”
      means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
      company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 

   

  “Proceeding”
      means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
      such as a deposition), whether commenced or threatened.

   

  “Rule
        144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
      from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
      as such Rule.

   

  “Securities”
      means the Shares, the Warrants, and the Warrant Shares.

   

  “Securities
        Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

   

  “Shares”
      means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares. 

   

  “Short
        Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
      deemed to include locating and/or borrowing Shares and/or ADSs). 

   

  “Sophisticated
        Investor” means a Person who is not an accredited investor, within the meaning of Rule 501 under the Securities Act, and has
      such knowledge and experience in financial and business matters that he or she is capable of evaluating the merits and risks of the prospective
      investment, or the Company reasonably believes immediately prior to making any sale that such purchaser comes within this description.

   

  “Subscription
        Amount” means, as to each Purchaser, the aggregate amount to be paid for the Units purchased hereunder as specified below such
      Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,” in United States
      dollars and in immediately available funds.

   

  “Subsidiary”
      means any subsidiary of the Company as set forth on Schedule 3.1(a) and shall, where applicable, also include any direct
      or indirect subsidiary of the Company formed or acquired after the date hereof.

   

  “Trading
        Day” means a day on which the principal Trading Market is open for trading.

   

  “Trading
        Market” means any of the following markets or exchanges on which the Common Stock are listed or quoted for trading on the date
      in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
      Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).

   

  

  
  
    2

  

  
     

  

  
   

  “Transaction
        Documents” means this Agreement, the Warrants, and all exhibits and schedules thereto and hereto and any other documents or
      agreements executed in connection with the transactions contemplated hereunder.

   

  “Transfer
        Agent” means Computershare, the current transfer agent of the Company and any successor transfer agent of the Company.

   

  “Units”
      means units of the Company, with each unit comprised of (i) one (1) Share and (ii) a Warrant to purchase one half of a share of Common
      Stock;

   

  “Warrants”
      means the warrant to purchase Common Stock delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which
      Warrant shall be exercisable immediately upon issuance and have a term of exercise equal to two (2) years from the initial exercise date,
      in the form of Exhibit A attached hereto.

   

  “Warrant
        Shares” means the shares of Common Stock issuable upon exercise of the Warrants.

   

  ARTICLE
        II.

  PURCHASE
        AND SALE

   

  2.1 Closing.

   

  (a)
      Purchase of Units; No Minimum Offering; Over-Subscription Option. Subject to the satisfaction (or waiver) of the terms and conditions
      of this Agreement, each Purchaser agrees, severally and not jointly, to purchase at Closing (as defined below), and the Company agrees
      to sell and issue to each Purchaser, severally and not jointly, at Closing, Units in principal amounts set forth on the signature pages
      attached hereto, attached hereto as Annex A, for each Purchaser affixed hereto. On the Closing Date (as defined below), upon the
      terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the
      parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $3,000,000
      of Units; provided, each Purchaser is committed only to purchase Units in the principal amount set forth on its signature page attached
      hereto. Each Purchaser acknowledges that that: (i) the Offering is being conducted on a “best efforts/no minimum basis” and
      that, therefore, the Company makes no representation or guarantee that $3,000,000 of Units will be sold in the Offering; (ii) no actual
      Units will be issued in connection with the Offering, with each Purchaser only receiving Shares and Warrants at the applicable Closing
      and (iii) the Company shall have the option, in its discretion, to increase the size of the Offering by an addition $3,000,000 worth
      of Units without notice to or approval of the Purchasers.

   

  (b)
      Closing Date. The initial closing of the purchase and sale of the Units (the “Closing”) shall take place on
      the date when all of the Transaction Documents have been executed and delivered by the applicable parties and the other conditions to
      the Closing set forth in Sections 2.2 and 2.3 have been satisfied or waived (or such later date as is mutually agreed to by the Company
      and the Purchaser(s)). There may be multiple Closings until the earlier of the Final Termination Date (as defined below) or such time
      as purchase for the sale of the Units are accepted (the date of any such Closing is hereinafter referred to as a “Closing Date”).
      Each Closing shall occur on a Closing Date remotely via the electronic exchange of documents and signatures. The Offering shall terminate
      on or before September 30, 2021 (the “Termination Date”). The Termination Date may be extended at the Company’s
      sole discretion for an additional 30 days, which extended Termination Date is referred to herein as the “Final Termination Date”.
      The Company reserves the right to terminate the Offering in its discretion following the initial Closing.

   

  (c)
      Form of Payment. At the times specified in Section 2.2, (i) each Purchaser shall deliver or cause to be delivered to the Company,
      via wire transfer in accordance with wire instructions provided by the Company, immediately available funds equal to such Purchaser’s
      Subscription Amount as set forth on the signature pages hereto executed by such Purchaser, (ii) the Company shall deliver or cause to
      be delivered to each Purchaser (x) a number of Shares equal to such Purchaser’s Subscription Amount divided by the Per Unit Purchase
      Price and (y) a Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 50% of
      such Purchaser’s Shares determined in the preceding clause (x), with an exercise price equal to $0.0975 per share subject to adjustment
      therein; and (iii) the Company and each Purchaser shall deliver the other items set forth in Section 2.2.

   

  

  
  
    3

  

  
     

  

  
    

  2.2 Deliveries.

   

  (a) On
      or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:

   

  (i)
      this Agreement duly executed by the Company; and

   

  (ii)
      a Warrant registered in the name of such Purchaser with such terms as determined in accordance with Section 2.1(c).

   

  (b) On
      or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:

   

  (i)
      this Agreement duly executed by such Purchaser; and

   

  (ii) such
      Purchaser’s Subscription Amount by wire transfer in accordance with wire instructions provided by the Company.

   

  (c) Within
      three (3) Business Days following the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser a copy of the
      irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a number of Shares as
      determined in accordance with Section 2.1(c), by book entry transfer registered in the Company’s share register in the name of
      the Purchaser or, at the request of the Purchaser, by physical delivery of a certificate evidencing such Shares, registered in the name
      of such Purchaser.

   

   2.3 Closing
        Conditions.

   

  (a) The
      obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

   

  (i) the
      accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
      in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as
      of a specific date therein in which case they shall be accurate as of such date);

   

  (ii) all
      obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
      and

   

  (iii) the
      delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.

   

  (b) The
      respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:

   

  (i) the
      accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
      in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
      a specific date therein in which case they shall be accurate as of such date);

   

  

  
  
    4

  

  
     

  

  
   

  (ii) all
      obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;

   

  (iii) the
      delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

   

  (iv) there
      shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

   

  (v) from
      the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or any Trading Market
      and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended
      or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading
      Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have
      occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect
      on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes
      it impracticable or inadvisable to purchase the Securities at the Closing.

   

  ARTICLE
        III.

  REPRESENTATIONS
        AND WARRANTIES

   

  3.1 Representations
        and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
      hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
      of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:

   

  (a) Subsidiaries.
      All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a). The Company owns, directly or
      indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued
      and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
      and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries
      or any of them in the Transaction Documents shall be disregarded.

   

  (b) Organization
        and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing,
      and, if applicable under the laws of the jurisdiction in which they are formed, in good standing under the laws of the jurisdiction of
      its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its
      business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective
      certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries
      is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which
      the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
      or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the
      legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets,
      business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material
      adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction
      Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such
      jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

   

  

  
  
    5

  

  
     

  

  
   

  (c) Authorization;
        Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
      by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
      execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
      transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company. This Agreement
      and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and,
      when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable
      against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
      reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as
      limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar
      as indemnification and contribution provisions may be limited by applicable law.

   

  (d) No
        Conflicts. Except as disclosed on Schedule 3.1(d), the execution, delivery and performance by the Company of this Agreement
      and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the
      transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company’s or
      any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict
      with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation
      of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
      anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
      credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the
      Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected; except
      in the case of clause (ii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

   

  (e) Issuance
        of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
      Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than
      restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the terms of the
      Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other
      than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock
      the maximum number of Common Stock issuable pursuant to this Agreement and the Warrants.

   

  (f) Capitalization.
      The Company is authorized to issue 600,000,000 shares of Common Stock of which, as of the date of this Agreement, (i) 229,918,829 shares
      were issued and outstanding, (ii) 53,178,063 shares are reserved for various planned issuances of shares and securities exercisable into
      shares, including warrants and options (the “Planned Issuances”). No Person has any right of first refusal, preemptive
      right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except
      for the Planned Issuances and except as a result of the purchase and sale of the Securities, there are no outstanding options, warrants,
      scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible
      into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the
      capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is
      or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance
      and sale of the Securities will not obligate the Company to issue Common Stock or other securities to any Person (other than the Purchasers)
      and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under
      any of such securities. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption
      or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
      is or may become bound to redeem a security of the Company or such Subsidiary.

    

  (g) Certain
        Fees. The Company may enter into arrangements pursuant to which brokerage or finder’s fees or commissions are or will be payable
      by the Company or its Subsidiaries to brokers, financial advisors consultants, finders, placement agents, investment bankers, banks or
      other Persons with respect to the transactions contemplated by the Transaction Documents. Other than for Persons engaged by any Purchaser,
      if any, the Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other
      Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction
      Documents.  

     

  

  
  
    6

  

  
     

  

  
   

  3.2 Representations
        and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
      date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
      as of such date):

   

  (a) Organization;
        Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
      under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
      or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
      to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
      Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
      limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
      party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
      the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited
      by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
      affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,
      injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
      law.

   

  (b) Own
        Account. Such Purchaser understands that the Securities are “restricted securities” and have not been registered under
      the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with
      a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state
      securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
      state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
      distribution of such Securities in violation of the Securities Act or any applicable state securities law. Such Purchaser is acquiring
      the Securities hereunder in the ordinary course of its business.

   

  (c) Purchaser
        Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
      it exercises any Warrants it will be (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or
      (a)(8) under the Securities Act, (ii) a Sophisticated Investor, or (iii) a Non U.S. Person as defined under Regulation S promulgated
      under the Securities Act. To the extent that the Purchaser is a non U.S. Person, the Purchaser (x) is not acquiring Securities for the
      account or benefit of any U.S. Person, (y) is not, at the time of execution of this Agreement, and will not be, at the time of the Closing,
      in the United States and (z) is not a “distributor” (as defined in Regulation S promulgated under the Securities Act). The
      Purchaser acknowledges that to the extent he or she is not a U.S. Person the offer and sale of securities contemplated hereunder have
      been made in accordance with Rule 903 under Regulation S, including but not limited to such offer and sale being made in an “offshore
      transaction” without any “directed selling efforts” in the United States as such terms are defined under Rule 902 of
      Regulation S. .

   

  (d) Experience
        of Such Purchaser; Acknowledgment of Risk. Such Purchaser, either alone or together with its representatives, has such knowledge,
      sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective
      investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic
      risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. Such Purchaser
      acknowledges that an investment in the Securities is speculative and subject to significant risks, including the risk that the Company’s
      business might failure, which could result in the loss of the Purchaser’s investment in the Company.

   

  (e) General
        Solicitation. Such Purchaser is not, to such Purchaser’s knowledge, purchasing the Securities as a result of any advertisement,
      article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over
      television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.

   

  

  
  
    7

  

  
     

  

  
   

  (f) Access
        to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
      and schedules thereto) and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive
      answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and
      risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations,
      business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain
      such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make
      an informed investment decision with respect to the investment.  Such Purchaser acknowledges and agrees that neither the Company
      nor any Affiliate of the Company has provided such Purchaser with any information or advice with respect to the Securities nor is such
      information or advice necessary or desired.

    

  (g) No
        Governmental Review. Such Purchaser understands that no United States federal or state agency or any other government or governmental
      agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in
      the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

   

  (h) Brokers.
      Except as set forth on Schedule 3.2(h), no agent, broker, investment banker, person or firm acting in a similar capacity
      on behalf of or under the authority of the Purchaser is or will be entitled to any broker’s or finder’s fee or any other
      commission or similar fee, directly or indirectly, for which the Company or any of its Affiliates after the Closing could have any liabilities
      in connection with this Agreement, any of the transactions contemplated by this Agreement, or on account of any action taken by the Purchaser
      in connection with the transactions contemplated by this Agreement.

   

  (i) Independent
        Advice. Such Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company
      to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.

   

  (j) Certain
        Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
      any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
      sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first
      received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
      of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
      case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s
      assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other
      portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of assets
      managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to
      other Persons party to this Agreement or to such Purchaser’s representatives, including, without limitation, its officers, directors,
      partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures
      made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing,
      for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty against, or a prohibition of, any
      actions with respect to the borrowing of, arrangement to borrow, identification of the availability of, and/or securing of, securities
      of the Company in order for such Purchaser (or its broker or other financial representative) to effect Short Sales or similar transactions
      in the future.

   

  (k) Non-Public
        Information. Such Purchaser acknowledges that, pursuant to applicable law, it may not trade in the securities of the Company on the
      basis of material, non-public information concerning the Company or its Subsidiaries, or share any material, non-public information concerning
      the Company or its Subsidiaries in its possession with any third party.

   

  

  
  
    8

  

  
     

  

  
   

  (l)
      Acknowledgment of Company Status. Such Purchaser acknowledges that (i) the Common Stock is not registered pursuant to Section
      12(b) or 12(g) of the Exchange Act, and the Company is not subject to the reporting requirements of Section 13(a) or 15(b) of the Exchange
      Act, and (ii) the Company was previously an “issuer” described under paragraph (i)(1)(i) of Rule 144.

   

  (m) No
        Other Representations. Such Purchaser acknowledges that, except for the representations and warranties made by the Company in this
      Agreement, neither the Company nor any representative of the Company makes or has made any other express or implied representation or
      warranty with respect to the Company or any of its Subsidiaries, and acknowledges that it has not relied upon or otherwise been induced
      by any such other express or implied representation or warranty.

   

  The
      Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser’s
      right to rely on the Company’s representations and warranties contained in this Agreement.

   

  ARTICLE
        IV.

  OTHER
        AGREEMENTS OF THE PARTIES

   

  4.1 Transfer
        Restrictions.

   

  (a) The
      Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
      other than pursuant to an effective registration statement or Rule 144, or to the Company or to an Affiliate of a Purchaser, the Company
      may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable
      to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
      does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee
      shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under this
      Agreement.

   

  (b) The
      Purchasers agree to the imprinting of a legend on any of the Securities in substantially following form:

   

  [NEITHER]
      THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
      COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
      AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
      STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
      OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON EXERCISE
      OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
      INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
      SUCH SECURITIES.

       

  4.2 Integration.
      The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
      Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the
      registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities
      for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing
      of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.

   

  4.3 Exercise
        Procedures. Each of the form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of
      the Purchasers in order to exercise the Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall
      be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required
      in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
      to exercise their Warrants. The Company shall honor exercises of the Warrants and shall deliver or cause to be delivered Warrant Shares
      in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

   

  

  
  
    9

  

  
     

  

  
   

  4.4 Shareholder
        Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
      is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution
      under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
      could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
      or under any other agreement between the Company and the Purchasers.

    

  4.5 Use
        of Proceeds. The Company and its Subsidiaries shall use the net proceeds from the sale of the Securities hereunder for general corporate
      and working capital purposes.

    

  4.6 Reservation
        of Common Stock. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at
      all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue
      Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.

    

  4.7 Equal
        Treatment of Purchasers. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
      Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
      also offered to all of the parties to such Transaction Documents. For clarification purposes, this provision constitutes a separate right
      granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
      as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
      or voting of Securities or otherwise.

    

  4.8 Form
        D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and
      to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
      determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
      applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly
      upon request of any Purchaser.

     

  ARTICLE
        V.

  MISCELLANEOUS

   

  5.1 Fees
        and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
      of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
      preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
      limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
      by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.

   

  5.2 Entire
        Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
      with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
      to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

   

  5.3 Notices.
      Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
      be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile
      at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30
      p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication
      is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
      hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd)
      Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
      by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
      signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
      material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file a press release disclosing
      any such material non-public information.

   

  

  
  
    10

  

  
     

  

  
   

  5.4 Amendments;
        Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
      the case of an amendment, by the Company and the Purchasers who purchased at least 50.1% in interest of the Shares based on the initial
      Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought,
      provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers),
      the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. Notwithstanding anything to
      the contrary herein, the Company may amend this Agreement without the consent of any Purchasers to add additional Purchaser parties hereto
      subsequent to the date of this Agreement and prior to the Final Termination Date. No waiver of any default with respect to any provision,
      condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default
      or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right
      hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and
      adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers
      shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section
      5.4 shall be binding upon each Purchaser and holder of Securities and the Company.

   

  5.5 Headings.
      The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
      of the provisions hereof.

   

  5.6 Successors
        and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
      The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
      (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
      or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
      by the provisions of the Transaction Documents that apply to the “Purchasers.”

   

  5.7 No
        Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
      assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in
      this Section 5.7.

   

  5.8 Governing
        Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
      by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
      of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
      contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
      directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
      sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
      sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
      any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
      and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction
      of any such court, that such Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
      personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified
      mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
      and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
      be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence a Proceeding
      to enforce any provisions of the Transaction Documents, then the prevailing party in such Proceeding shall be reimbursed by the non-prevailing
      party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution
      of such Proceeding.

   

  

  
  
    11

  

  
     

  

  
   

  5.9 Survival.
      The representations and warranties contained herein shall survive the Closing and the delivery of the Securities for the applicable statute
      of limitations.

   

  5.10 Execution.
      This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
      and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
      the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
      of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
      behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original
      thereof.

   

  5.11 Severability.
      If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
      void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
      and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
      to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
      covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
      terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
      unenforceable.

   

  5.12 Rescission
        and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any
      of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document
      and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind
      or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
      whole or in part without prejudice to its future actions and rights; provided, however, that, in the case of
      a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any Shares and/or Shares subject to any
      such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for
      such shares and the restoration of such Purchaser’s right to acquire such shares pursuant to such Purchaser’s Warrant (including,
      issuance of a replacement warrant certificate evidencing such restored right).

   

  5.13 Replacement
        of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
      issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
      and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
      of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
      third-party costs (including customary indemnity but without any requirement to post any surety bond)) associated with the issuance of
      such replacement Securities.

   

  5.14 Remedies.
      In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
      and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
      not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
      hereby agree to waive and not to assert in any Proceeding for specific performance of any such obligation the defense that a remedy at
      law would be adequate.

    

  5.15 Independent
        Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several
      and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
      of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
      and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
      a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
      with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
      protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction
      Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
      Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The
      Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
      because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
      in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company
      and the Purchasers collectively and not between and among the Purchasers.

   

  

  
  
    12

  

  
     

  

  
    

  5.18 Saturdays,
        Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
      herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

   

  5.19 Construction.
      The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
      and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
      not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
      share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
      stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

   

  5.20 WAIVER
          OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH
        KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND
        EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

   

  (Signature
        Pages Follow)

   

  

  
  
    13

  

  
     

  

  
   

  IN
      WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
      signatories as of the date first indicated above.

   

  	METRO ONE TELECOMMUNICATIONS, INC.	 	Address for Notice:
	 	 	
          30 North Gould Street, Suite 2990

          Sheridan, WY 82801

          Attention: Elchanan Maoz, President

        
	By:	 	 	Email: nani@maozeverest.com
	 	Name: Elchanan Maoz	 	 
	 	Title: President	 	 
	 	 	 
	With a copy to (which shall not constitute notice):	 	 

   

  Olshan
      Frome Wolosky LLP

  1325
      Avenue of the Americas

  New
      York, NY 100019

  Attention:
      Margaret C. Bae

  E-Mail:
      mbae@olshanlaw.com

   

  [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK]

   

  [SIGNATURE
      PAGE FOR PURCHASER FOLLOWS]

   

  

  
  
    14

  

  
     

  

  
   

  [PURCHASER
      SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]

   

  IN
      WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
      as of the date first indicated above.

   

  Name
      of Purchaser: ________________________________________________________

   

  Signature
        of Authorized Signatory of Purchaser: __________________________________

   

  Name
      of Authorized Signatory: ____________________________________________________

   

  Title
      of Authorized Signatory: _____________________________________________________

   

  Email
      Address of Authorized Signatory: _____________________________________________

   

  Facsimile
      Number of Authorized Signatory: __________________________________________

   

  Address
      for Notice to Purchaser:

   

  Address
      for Delivery of Securities to Purchaser (if not same as address for notice):

   

  Subscription
      Amount: $_____________

   

  Units:

  Shares:________________

   

  Warrants:
      _________________

   

  Social
      Security/EIN Number: _______________________

   

  [SIGNATURE
      PAGES CONTINUE]

   

  

  
  
    15

  

  
     

  

  
   

  Exhibit
          A

   

  Form
      of Warrant

   

  See
      attached.

   

  

  
  
    16Exhibit 10.7

   

  THIS
      WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY
      MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
      UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED
      UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.

   

  	Date of Issuance	 	Void after
	[____________], 2021	 	[____________], 2023

    

  METRO
      ONE TELECOMMUNICATIONS, INC.

      WARRANT TO PURCHASE SHARES COMMON STOCK

   

  In
      connection with and as consideration for the Holder (as defined below) purchasing certain shares of Common Stock pursuant to that certain
      Common Stock Purchase Agreement (the “Purchase Agreement”), dated as of September 3, 2021, this Warrant is issued
      to [_____________] or its assigns (the “Holder”) by METRO ONE TELECOMMUNICATIONS, INC., a Delaware corporation
      (the “Company”).

   

  1.
      Purchase of Shares.

   

  1.1
      Number of Shares. Subject to the terms and conditions set forth herein, the Holder is entitled, upon surrender of this Warrant
      at the principal office of the Company (or at such other place as the Company shall notify the Holder in writing), to purchase from the
      Company up to an aggregate of [__________] fully paid and nonassessable shares of the Company’s Common Stock (the “Common
        Stock”).

   

  1.2
      Exercise Price. The exercise price for the shares of Common Stock issuable pursuant to this Section 1 (the “Shares”)
      shall be $0.0975 per share (the “Exercise Price”). The Shares and the Exercise Price shall be subject to adjustment
      pursuant to Section 5 hereof.

   

  2.
      Exercise Period. This Warrant shall be exercisable, in whole or in part, during the term commencing on [__________], 2021 and
      ending at 5:00 p.m. ET on [__________]1, 2022 (the “Exercise Period”).

   

   

   

   

  

  
  
     

  

  
  1 NTD: to be two years from date of issuance.

   

  

  
  
    1

  

  
     

  

  
    

  3.
      Method of Exercise.

   

  3.1
      While this Warrant remains outstanding and exercisable in accordance with Section 2 above, the Holder may exercise, in whole or in part,
      the purchase rights evidenced hereby. Such exercise shall be effected by:

   

  (a)
      the surrender of the Warrant, together with a duly executed copy of the Notice of Exercise attached hereto, to the Secretary of the Company
      at its principal office (or at such other place as the Company shall notify the Holder in writing); and

   

  (b)
      the payment to the Company of an amount equal to the aggregate Exercise Price for the number of Shares being purchased.

   

  3.2
      Each exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which this
      Warrant is surrendered to the Company as provided in Section 3.1 above.

   

  3.3
      As soon as practicable after the exercise of this Warrant in whole or in part, and in any event within twenty (20) days thereafter (such
      date, the “Share Delivery Date”), the Company at its expense will cause the Shares purchased hereunder to be transmitted
      by (x) the Company’s transfer agent (the “Transfer Agent”) to the Holder by crediting the account of the Holder’s
      or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”)
      if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
      of the Shares to or resale of the Shares by the Holder or (B) the Shares are eligible for resale by the Holder pursuant to Rule 144,
      and (y) otherwise by book entry transfer registered in the Company’s share register in the name of the Holder or its designee (or
      at the request of the Holder, by physical delivery of a certificate, registered in the name of the Holder or its designee), for the number
      of Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise.
      The Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have
      become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company
      of the Exercise Price, prior to the issuance of such Shares, having been paid.

   

  3.4
      In case such exercise is in part only, the Company shall, at the request of the Holder, issue a new warrant or warrants (dated the date
      hereof) of like tenor, calling in the aggregate on the face or faces thereof for the number of Shares equal to the number of such Shares
      described in this Warrant minus the number of such Shares purchased by the Holder upon all exercises made in accordance with Section
      3.1 above.

   

  4.
      Covenants of the Company.

   

  4.1
      Notices of Record Date. In the event of any taking by the Company of a record of the holders of any class of securities for the
      purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend which is the same as
      cash dividends paid in previous quarters and stock dividends) or other distribution, the Company shall provide the Holder, at least ten
      (10) days prior to such record date, a notice specifying the date on which any such record is to be taken for the purpose of such dividend
      or distribution.

   

  4.2
      Covenants as to Exercise Shares. The Company covenants and agrees that all Shares that may be issued upon the exercise of the
      rights represented by this Warrant will, upon issuance in accordance with the terms hereof, be validly issued and outstanding, fully
      paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance thereof. The Company further covenants
      and agrees that the Company will at all times during the Exercise Period, have authorized and reserved, free from preemptive rights,
      a sufficient number of shares of Common Stock to provide for the exercise of the rights represented by this Warrant. If at any time during
      the Exercise Period the number of authorized but unissued shares of Common Stock shall not be sufficient to permit exercise of this Warrant,
      the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued
      shares of Common Stock to such number of shares as shall be sufficient for such purposes.

   

  

  
  
    2

  

  
     

  

  
   

  5.
      Adjustment of Exercise Price and Number of Shares. The number and kind of Shares purchasable upon exercise of this Warrant and
      the Exercise Price shall be subject to adjustment from time to time as follows:

   

  5.1
      Subdivisions Other Issuances. If the Company shall at any time after the issuance but prior to the expiration of this Warrant
      subdivide its Common Stock, by split-up or otherwise, or issue additional shares of its Common Stock as a dividend with respect to any
      shares of its Common Stock, the number of Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased
      in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments shall
      also be made to the Exercise Price payable per share, but the aggregate Exercise Price payable for the total number of Shares purchasable
      under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 5.1 shall become effective at the close of
      business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that
      no record date is fixed, upon the making of such dividend.

   

  5.2
      Reclassification, Reorganization and Consolidation. In case of any reclassification, capital reorganization or change in the capital
      stock of the Company (other than as a result of a subdivision, or stock dividend provided for in Section 5.1 above), then, as a condition
      of such reclassification, reorganization or change, lawful provision shall be made, and duly executed documents evidencing the same from
      the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right at any time prior to the expiration
      of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares
      of stock and other securities or property receivable in connection with such reclassification, reorganization or change by a holder of
      the same number and type of securities as were purchasable as Shares by the Holder immediately prior to such reclassification, reorganization
      or change. In any such case appropriate provisions shall be made with respect to the rights and interest of the Holder so that the provisions
      hereof shall thereafter be applicable with respect to any shares of stock or other securities or property deliverable upon exercise hereof,
      and appropriate adjustments shall be made to the Exercise Price per Share payable hereunder, provided the aggregate Exercise Price
      shall remain the same.

   

  5.3
      Notice of Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of
      the Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of Shares or other
      securities or property thereafter purchasable upon exercise of this Warrant.

   

  

  
  
    3

  

  
     

  

  
   

  6.
      No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
      of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price
      then in effect.

   

  7.
      No Stockholder Rights. Prior to exercise of this Warrant, the Holder shall not be entitled to any rights of a stockholder with
      respect to the Shares, including (without limitation) the right to vote such Shares, receive dividends or other distributions thereon,
      exercise preemptive rights or be notified of stockholder meetings, and, except as otherwise provided in this Warrant, such Holder shall
      not be entitled to any stockholder notice or other communication concerning the business or affairs of the Company. Upon the exercise
      of the Warrant, if not already a party thereto, the Holder shall execute a joinder to each of the Transaction Documents (as defined in
      the Purchase Agreement) then in effect, and any other related agreements or instruments as reasonably requested by the Company at such
      time. If the Holder is already party to the Transaction Documents, the Holder agrees that upon the exercise of the Warrant, the Shares
      shall be subject to the terms and conditions of the Purchase Agreement in all respects.

   

  8.
      Transfer of Warrant. Subject to compliance with applicable federal and state securities laws, the last sentence of this Section
      8 and any other contractual restrictions between the Company and the Holder contained herein, this Warrant and all rights hereunder are
      transferable in whole or in part by the Holder to any person or entity upon written notice to the Company; provided, that the
      Holder shall not make any such transfer to any of the Company’s competitors as such is reasonably determined by the Company. Within
      a reasonable time after the Company’s receipt of an executed Assignment Form in the form attached hereto, the transfer shall be
      recorded on the books of the Company upon the surrender of this Warrant, properly endorsed, to the Company at its principal offices.
      In the event of a partial transfer, the Company shall issue to the new holders one (1) or more appropriate new warrants. Notwithstanding
      the foregoing, any transfer of this Warrant and any rights hereunder shall be subject to the terms and conditions regarding transfers
      set forth in the Company’s Bylaws, as amended from time to time.

   

  9.
      Governing Law. This Warrant shall be governed by and construed under the laws of the State of New York as applied to agreements
      among New York residents, made and to be performed entirely within the State of New York.

   

  10.
      Successors and Assigns. The terms and provisions of this Warrant shall inure to the benefit of, and be binding upon, the Company
      and the holders hereof and their respective successors and assigns.

   

  11.
      Counterparts. This Warrant may be executed in two or more counterparts, each of which shall be deemed an original, but all of
      which together shall constitute one and the same instrument.

   

  12.
      Titles and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered
      in construing or interpreting this Warrant.

   

  13.
      Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed effectively
      given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during
      normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having been sent
      by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized
      overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective
      parties at the following addresses (or at such other addresses as shall be specified by notice given in accordance with this Section
      13):

   

  

  
  
    4

  

  
     

  

  
   

  If
      to the Company:

   

  METRO
        ONE TELECOMMUNICATIONS, INC.

      30 North Gould Street, Suite 2990

      Sheridan, WY 82801

  

  Attention:
      Elchanan Maoz, President

   

  If
      to Holder:

   

  At
      the address shown on the signature page hereto.

   

  14.
      Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Warrant, the prevailing party
      shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such
      party may be entitled.

   

  15.
      Entire Agreement; Amendments and Waivers. This Warrant and any other documents delivered pursuant hereto constitute the full and
      entire understanding and agreement between the parties with regard to the subjects hereof and thereof. Nonetheless, any term of this
      Warrant may be amended and the observance of any term of this Warrant may be waived (either generally or in a particular instance and
      either retroactively or prospectively), with the written consent of the Company and the Holder; or if this Warrant has been assigned
      in part, by the holders or rights to purchase a majority of the shares originally issuable pursuant to this Warrant.

   

  16.
      Severability. If any provision of this Warrant is held to be unenforceable under applicable law, such provision shall be excluded
      from this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable
      in accordance with its terms.

   

  [Signature
      Page Follows]

   

  

  
  
    5

  

  
     

  

  
   

  IN
      WITNESS WHEREOF, the parties have executed this Warrant as of the date first written above.

   

  	 	METRO ONE TELECOMMUNICATIONS, INC.
	 	 
	 	By:	   
	 	 	Name:	Elchanan Maoz
	 	 	Title:	President

   

  	ACKNOWLEDGED AND AGREED:	 	 
	 	 	 
	HOLDER	 	 
	 	 	 
	By:		 	 	 
	 	Name:	 	 	 	 	 
	 	Title:	 	 	 	 	 

   

  	Address:		 	 	 	 
	 		 	 	 	 
	 	 	 	 	 	 

   

  

  
  
    6

  

  
     

  

  
   

  

  NOTICE
      OF EXERCISE

   

  METRO
      ONE TELECOMMUNICATIONS, INC.

   

  Attention:
      President

   

  The
      undersigned hereby elects to purchase, pursuant to the provisions of the Warrant, as follows:

   

  _____________
      shares of Common Stock pursuant to the terms of the attached Warrant, and tenders herewith payment in cash of the Exercise Price of such
      Shares in full.

   

  ☐ Check
      here if requesting delivery via book entry transfer.

   

  ☐ Check
      here if requesting delivery as a certificate to the following name and to the following address:

   

  	Issue to:	
	 	
	 	

    

  ☐ Check
      here if requesting delivery by Deposit/Withdrawal at Custodian as follows:

   

  	DTC Participant:	 
	DTC Number:	 
	Account Number:	 

   

  	Date: ___________________	HOLDER:
	 	 
	 	By:	
	 	 	Name:	 
	 	 	Title:	 

   

  	 	Address:	
	 	 	
	 	 	

   

  	Name in which shares should be registered:	 
	 	
		 

   

  

  
  
    7

  

  
     

  

  
  

   

  ASSIGNMENT
      FORM

   

  (To
      assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

   

  For
        Value Received, the foregoing Warrant and all rights
      evidenced thereby are hereby assigned to

   

  	Name:	 
	 	(Please Print)
	 	 
	Address:	 
	 	(Please Print)
	 	 
	Dated:	                                      
	 	 
	 	 
	Holder’s

            Signature:	 
	 	 
	Holder’s

            Address:	 
	 	 

  NOTE:
      The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant. Officers of corporations
      and those acting in a fiduciary or other representative capacity should provide proper evidence of authority to assign the foregoing
      Warrant.

   

  

  
  
    8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]